1. CNBC is running exposure on how cartel of select FIIs holding 20-22% of 25% public float in all Adani group companies (remaining 75% with promoter)
2. All these 7 select FIIs have 95-99% of their exposure to only Adani group companies!!
3. They have filed a complaint with SEBI against the cartel

*DFM Foods Ltd.* | *CMP* Rs. 437 | *M Cap* Rs. 2197 Cr | *52 W H/L* 444/170
(Nirmal Bang Retail Research)
*Result is declining*
Revenue from Operations came at Rs. 132.5 Cr (-2.1% QoQ, 20.7% YoY) vs QoQ Rs. 135.4 Cr, YoY Rs. 109.8 Cr
EBIDTA came at Rs. 6.5 Cr (-60.6% QoQ, 209% YoY) vs QoQ Rs. 16.5 Cr, YoY Rs. 2.1 Cr
EBITDA Margin came at 4.9% vs QoQ 12.2%, YoY 1.9%
Adj. PAT came at Rs. 0.9 Cr vs QoQ Rs. 9.5 Cr, YoY Rs. -1.2 Cr
Quarter EPS is Rs. 0.2
Share is trading at P/E of 76.5x TTM EPS

*JK Cement Ltd.* | *CMP* Rs. 2851 | *M Cap* Rs. 22024 Cr | *52 W H/L* 3150/1041
(Nirmal Bang Retail Research)
*Result below expectation*
Revenue from Operations came at Rs. 2052.5 Cr (16.6% QoQ, 38.9% YoY) vs expectation of Rs. 2043.4 Cr, QoQ Rs. 1760.1 Cr, YoY Rs. 1477.4 Cr
EBIDTA came at Rs. 439.1 Cr (-2.2% QoQ, 26.8% YoY) vs expectation of Rs. 477.1 Cr, QoQ Rs. 448.8 Cr, YoY Rs. 346.3 Cr
EBITDA Margin came at 21.4% vs expectation of 23.4%, QoQ 25.5%, YoY 23.4%
Adj. PAT came at Rs. 230.2 Cr vs expectation of Rs. 263.4 Cr, QoQ Rs. 238.3 Cr, YoY Rs. 178.4 Cr
Quarter EPS is Rs. 29.8
Share is trading at EV/EBITDA of 12.1x FY23 EBITDA

*Edelweiss Financial Services Ltd. -C* | *CMP* Rs. 72 | *M Cap* Rs. 6780 Cr | *52 W H/L* 92/34
(Nirmal Bang Retail Research)
*Result continued to remain weak*
Core revenue (excluding other income and gain on fair value changes) was flat YoY at Rs. 1968 Cr (QoQ Rs. 1752 Cr)
Core PBT came at Rs. -1958 Cr vs YoY Rs. -2808 Cr, QoQ Rs. -575 Cr
Core PBT remained weak due to higher credit costs.
Wealth AUA grew 36% YoY with ROE of 15.6%
Performance of NBFC & HFC remained subdued with elevated provisioning.
NBFC GNPA was at 5.1%. Will continue to focus on reducing the wholesale book.
HFC GNPA was at 2.9% and posted a loss at bottomline.
Life Insurance witnessed 25% YoY growth in Individual APE in FY21. Co was the only player in the industry to have registered growth every month in FY21.
General Insurance witnessed 49% yoy Gross Direct Premium Income (GDPI) growth in FY21 against Industry growth of 5%.

_Segment Revenue_
Agency Business came at Rs. 386 Cr vs YoY Rs. 286 Cr, QoQ Rs. 348 Cr
Capital Based Business came at Rs. 2784 Cr vs YoY Rs. 792 Cr, QoQ Rs. 490 Cr
Life Insurance came at Rs. 620 Cr vs YoY Rs. 317 Cr, QoQ Rs. 608 Cr
ARC came at Rs. 546 Cr vs YoY Rs. 356 Cr, QoQ Rs. 371 Cr
Total Income came at Rs. 3058 Cr vs YoY Rs. 1966 Cr, QoQ Rs. 2184 Cr
_Segment Result_
Capital Based Business came at Rs. 549 Cr vs YoY Rs. -2608 Cr, QoQ Rs. -399 Cr
Life Insurance came at Rs. -65 Cr vs YoY Rs. -126 Cr, QoQ Rs. -65 Cr
Total Segmental EBIT came at Rs. 565 Cr vs YoY Rs. -2819 Cr, QoQ Rs. -137 Cr
PAT came at Rs. 629 Cr vs YoY Rs. -2245 Cr, QoQ Rs. -70 Cr
Quarter EPS is Rs. 6.7
Share is trading at P/E of 20.7x FY22E EPS & 0.9x trailing P/BV

*Parag Milk Foods Ltd.* | *CMP* Rs. 152 | *M Cap* Rs. 1275 Cr | *52 W H/L* 158/83
(Nirmal Bang Retail Research)
*Result is declining*
Revenue from Operations came at Rs. 434.3 Cr (-8.3% QoQ, -18.8% YoY) vs QoQ Rs. 473.6 Cr, YoY Rs. 535.2 Cr
EBIDTA came at Rs. 18.4 Cr (-47.6% QoQ, -53.9% YoY) vs QoQ Rs. 35.1 Cr, YoY Rs. 40 Cr
EBITDA Margin came at 4.2% vs QoQ 7.4%, YoY 7.5%
Adj. PAT came at Rs. -9.6 Cr vs QoQ Rs. 11.2 Cr, YoY Rs. 10.1 Cr
Quarter EPS is Rs. -1.1
Share is trading at P/E of 14.4x FY22E EPS

*Cochin Shipyard Ltd.* | *CMP* Rs. 413 | *M Cap* Rs. 5430 Cr | *52 W H/L* 427/218
(Nirmal Bang Retail Research)
*Result ahead of Expectation*
Revenue from Operations came at Rs. 1080.3 Cr (44.3% QoQ, 32.3% YoY) vs expectation of Rs. 924.9 Cr, QoQ Rs. 748.7 Cr, YoY Rs. 816.7 Cr
EBIDTA came at Rs. 259 Cr (-18.6% QoQ, 58.9% YoY) vs expectation of Rs. 239.5 Cr, QoQ Rs. 318 Cr, YoY Rs. 163 Cr
EBITDA Margin came at 24% vs expectation of 25.9%, QoQ 42.5%, YoY 20%
Adj. PAT came at Rs. 229.6 Cr vs expectation of Rs. 182.9 Cr, QoQ Rs. 229.5 Cr, YoY Rs. 138.8 Cr
Quarter EPS is Rs. 17.5
Share is trading at P/E of 8.9x TTM EPS

*CG Power & Industrial Solutions Ltd.* | *CMP* Rs. 82 | *M Cap* Rs. 10972 Cr | *52 W H/L* 92/5
(Nirmal Bang Retail Research)
*Result improved*
Revenue from Operations came at Rs. 1117.8 Cr (36.4% QoQ, 81.4% YoY) vs QoQ Rs. 819.5 Cr, YoY Rs. 616.3 Cr
EBIDTA came at Rs. 114.5 Cr (18.6% QoQ, -237.2% YoY) vs QoQ Rs. 96.6 Cr, YoY Rs. -83.5 Cr (EbITDA for Q4 is adjusted for Rs.46cr legacy one off expenses accounted during the quarter)
EBITDA Margin came at 10.2% vs QoQ 11.8%, YoY -13.5%
Adj. PAT came at Rs. 64 Cr vs QoQ Rs. 481.8 Cr, YoY Rs. -115.2 Cr (lot of variation in PAT is on account of Exceptional in all the quarter)
Quarter EPS is Rs. 0.5

*DLF LTD.* | *CMP* Rs. 310 | *M Cap* Rs. 76735 Cr | *52 W H/L* 333/130
(Nirmal Bang Retail Research)
Sales Booking came at Rs.1058cr vs QoQ Rs.1022cr YoY Rs.325cr
*Result ok*
Revenue from Operations came at Rs. 1712.6 Cr (11% QoQ, 1.1% YoY) vs QoQ Rs. 1543 Cr, YoY Rs. 1694.2 Cr
EBIDTA came at Rs. 453.9 Cr (-9.1% QoQ, 43.3% YoY) vs QoQ Rs. 499.1 Cr, YoY Rs. 316.7 Cr
EBITDA Margin came at 26.5% vs QoQ 32.3%, YoY 18.7%
Adj. PAT came at Rs. 480.9 Cr vs QoQ Rs. 451.2 Cr, YoY Rs. -1527.1 Cr
Quarter EPS is Rs. 1.9
Share is trading at P/E of 48.5x FY22E EPS

Indian jewellers lift shutters; discounts prevail in top hubs
https://www.livemint.com/market/commodities/indian-jewellers-lift-shutters-discounts-prevail-in-top-hubs-11623455997384.html

India's gold imports in May surged over nine-fold from 2020's low base to 12 tonnes.

EKC One of the biggest suppliers of oxygen cylinders in the country has been blacklisted for two years by the Union health ministry for failure to deliver orders on time and its ‘non commitment to the national cause’ amid the pandemic. Pls inform all your followers to sell it and run away from EVEREST Kanto Cylinders
Read more at:
https://economictimes.indiatimes.com/news/india/key-o2-cylinder-provider-blacklisted-for-supply-failure/articleshow/83443667.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

Iron ore price correction delayed as global steel demand tops 2bn tonnes for first time ever - MINING.COM
https://www.mining.com/iron-ore-price-correction-delayed-as-global-steel-demand-tops-2bn-tonnes-first-time-ever/

Zydus Cadila has received tentative approval from the USFDA to market Osimertinib Tablets in the strengths of 40 mg and 80 mg (US RLD: Tagrisso Tablets).
Osimertinib is used to treat lung cancer. It belongs to a class of drugs known as kinase inhibitors. Osimertinib works by slowing or stopping the growth of cancer cells. It binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors.
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad. The group now has 318 approvals and has so far filed over 400 ANDAs since the commencement o

One more positive news

*How to create more Wealth through Share Market..?*

Many of us know Warren Buffett, the most successful investor in the world. He is a value investor. He learned value investing from Benjamin Graham. Graham is considered the father of Value Investing.

Buffett started his investment as a value investor as taught by Graham. However, over time, he has modified that approach and become more successful.

Graham buys an undervalued stock and sells it at a fair price. This is a " Buy low and sell high"strategy. It is a quantitative approach. You do not need to know anything about the company except for its numbers. You see good profit, low valuation, good financial condition, you can buy it without even knowing what the company does. It is very easy and quick. With good diversification and margin of safety, you can easily beat the market.

Buffett followed this quantitative approach but he found that soon after he sold the stocks, certain stocks tend to get higher. He found that the company with "Moat"continues to rise.
He is influenced by another great investor, Fisher. Fisher recommends a " Buy & Hold" strategy.

Buffett merges these two strategies and created his unique style.
He selects companies based on qualitative analysis with a good "Moat". These companies possess a " Durable Competitive Advantage" over their competitors. But he buys only when it is available at an undervaluation. He holds the company for a long time.

Buffett is 85% Graham and 15% Fisher.

*Happy Investing !!!*

Sun TV – First Cut – Ebitda and Ad revenue beat estimates

·         Q4 Net Profit Rs450cr (up 80% YoY) - Estimate Rs425cr

·         Revenue Rs782cr (up 6.4% YoY) - Estimate Rs812.2cr

·         Other income Rs50.59cr (down 11% YoY) – Estimates Rs57.7cr

·         Ebitda Rs547cr (up 8.5% YoY) - estimate 561cr

·         Q4 Subscription revenue Rs428cr

·         4Q Advertisement Revenue Rs315cr (up 8% YoY) – expectation flat growth 

BEML:
Q4 SL NET PROFIT 1.60B RUPEES VS 1.86B (YOY); EST 1.5B | 293M (QOQ)

Q4 REVENUE 17.74B RUPEES VS 10.66B (YOY)

CO BOARD RECOMMENDED A FINAL DIVIDEND OF 1.20 RUPEES PER SHARE

Centuryply concall

MDF:

150000 CBM we did in FY21 vs our capacity of 180000 CBM. We cant match demand since it is very high but we have room to grow.

Q - MDF cannibalize Plywood?
A - Not at all. There is a segment for each of our products. We had the same thought but now we are sure and hence we are going all in on MDF.

Q - Impact of Imports?
A - We are not worried. At least for next 18 months as there is enough demand. We are also in talk with Govt. ADD might come in.

Q - MDF margin at 27%. Is there room for leverage?
A - Not expecting higher margins. We can maintain it.


Both Plywood and MDF, unorganized are taking a bigger hit cos of RM procurement and working capital.

We want to triple our MDF share. Which is visible in our investments. Between 2015 to 2022, of the total cumulative capex of 1200 Cr, 575 Cr was in MDF. The final MDF expansion will come online in FY23.


Q – You have 180000 CBM in MDF. Rushil has added capacity. Greenpanel added last year. What is the scenario in India?
A – India total capacity is 1.5 Mn CBM. If you add ours and Rushil expansion, it will be 2Mn CBM. To give a perspective, 50 Mn CBM plus is China capacity. We have a long way to go.

Plywood:

Our run rate has been 1250 Cr. FY22, we had planned to do 1500 Cr through some capex and outsourcing by Q1 has been impacted. Long term, we can do 2000 Cr when all the capex is over. At 13.5 to 14% margins. We are bullish because of the growth in the last 2 quarters

Marksans has announced that one of the world's largest pharma funds Orbimed is picking up10.7% stake of Rs 365 cr. Also, funds to be used for growth as it is a zero debt co. Positive